• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巨噬细胞在结缔组织病相关间质性肺疾病中的作用:聚焦于分子机制和潜在治疗策略。

The Role of Macrophages in Connective Tissue Disease-Associated Interstitial Lung Disease: Focusing on Molecular Mechanisms and Potential Treatment Strategies.

机构信息

Graduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan.

School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan.

出版信息

Int J Mol Sci. 2023 Jul 26;24(15):11995. doi: 10.3390/ijms241511995.

DOI:10.3390/ijms241511995
PMID:37569370
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10419312/
Abstract

Connective tissue disease-associated interstitial lung disease (CTD-ILD) is a severe manifestation of CTD that leads to significant morbidity and mortality. Clinically, ILD can occur in diverse CTDs. Pathologically, CTD-ILD is characterized by various histologic patterns, such as nonspecific interstitial pneumonia, organizing pneumonia, and usual interstitial pneumonia. Abnormal immune system responses have traditionally been instrumental in its pathophysiology, and various changes in immune cells have been described, especially in macrophages. This article first briefly overviews the epidemiology, clinical characteristics, impacts, and histopathologic changes associated with CTD-ILD. Next, it summarizes the roles of various signaling pathways in macrophages or products of macrophages in ILD, helped by insights gained from animal models. In the following sections, this review returns to studies of macrophages in CTD-ILD in humans for an overall picture of the current understanding. Finally, we direct attention to potential therapies targeting macrophages in CTD-ILD in investigation or in clinical trials, as well as the future directions regarding macrophages in the context of CTD-ILD. Although the field of macrophages in CTD-ILD is still in its infancy, several lines of evidence suggest the potential of this area.

摘要

结缔组织病相关性间质性肺疾病(CTD-ILD)是 CTD 的严重表现形式,可导致显著的发病率和死亡率。临床上,ILD 可发生于多种 CTD。从病理学角度来看,CTD-ILD 的特征是存在各种组织学模式,如非特异性间质性肺炎、机化性肺炎和寻常间质性肺炎。异常的免疫系统反应一直是其病理生理学的关键因素,已经描述了各种免疫细胞的变化,尤其是巨噬细胞。本文首先简要概述了 CTD-ILD 的流行病学、临床特征、影响因素和组织病理学变化。接下来,它通过动物模型获得的见解,总结了各种信号通路在巨噬细胞或巨噬细胞产物在 ILD 中的作用。在接下来的部分中,本综述回顾了人类 CTD-ILD 中巨噬细胞的研究,以全面了解目前的认识。最后,我们将注意力转向针对 CTD-ILD 中巨噬细胞的潜在治疗方法,包括正在调查或临床试验中的治疗方法,以及 CTD-ILD 背景下巨噬细胞的未来方向。尽管 CTD-ILD 中巨噬细胞的研究领域仍处于起步阶段,但有几项证据表明该领域具有潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e9b/10419312/bd0e5d5c9201/ijms-24-11995-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e9b/10419312/52a7a7f78729/ijms-24-11995-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e9b/10419312/ece6bb4e6869/ijms-24-11995-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e9b/10419312/bd0e5d5c9201/ijms-24-11995-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e9b/10419312/52a7a7f78729/ijms-24-11995-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e9b/10419312/ece6bb4e6869/ijms-24-11995-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e9b/10419312/bd0e5d5c9201/ijms-24-11995-g003.jpg

相似文献

1
The Role of Macrophages in Connective Tissue Disease-Associated Interstitial Lung Disease: Focusing on Molecular Mechanisms and Potential Treatment Strategies.巨噬细胞在结缔组织病相关间质性肺疾病中的作用:聚焦于分子机制和潜在治疗策略。
Int J Mol Sci. 2023 Jul 26;24(15):11995. doi: 10.3390/ijms241511995.
2
Relationship between idiopathic interstitial pneumonias (IIPs) and connective tissue disease-related interstitial lung disease (CTD-ILD): A narrative review.特发性间质性肺炎(IIPs)与结缔组织病相关间质性肺疾病(CTD-ILD)的关系:叙述性综述。
Respir Investig. 2024 May;62(3):465-480. doi: 10.1016/j.resinv.2024.03.006. Epub 2024 Apr 1.
3
Comparison of clinical courses and mortality of connective tissue disease-associated interstitial pneumonias and chronic fibrosing idiopathic interstitial pneumonias.结缔组织病相关性间质性肺炎与慢性纤维化特发性间质性肺炎的临床过程和死亡率比较。
Kaohsiung J Med Sci. 2019 Jun;35(6):365-372. doi: 10.1002/kjm2.12066. Epub 2019 Mar 26.
4
Review series: Aspects of interstitial lung disease: connective tissue disease-associated interstitial lung disease: how does it differ from IPF? How should the clinical approach differ?综述系列:间质性肺病的各个方面:结缔组织病相关间质性肺病:它与特发性肺纤维化有何不同?临床方法应如何有所不同?
Chron Respir Dis. 2011;8(1):53-82. doi: 10.1177/1479972310393758.
5
Interstitial Lung Disease Associated with Connective Tissue Diseases.特发性间质性肺炎与结缔组织病相关性间质性肺疾病
Adv Exp Med Biol. 2021;1304:73-94. doi: 10.1007/978-3-030-68748-9_5.
6
Connective tissue disease-associated interstitial lung disease.结缔组织病相关间质性肺疾病。
Pulmonology. 2022 Mar-Apr;28(2):113-118. doi: 10.1016/j.pulmoe.2020.01.004. Epub 2020 Feb 7.
7
Idiopathic Interstitial Pneumonia Associated With Autoantibodies: A Large Case Series Followed Over 1 Year.与自身抗体相关的特发性间质性肺炎:一项为期1年的大型病例系列研究
Chest. 2017 Jul;152(1):103-112. doi: 10.1016/j.chest.2017.03.004. Epub 2017 Mar 12.
8
Comparison of characteristics of connective tissue disease-associated interstitial lung diseases, undifferentiated connective tissue disease-associated interstitial lung diseases, and idiopathic pulmonary fibrosis in Chinese Han population: a retrospective study.中国汉族人群中结缔组织病相关间质性肺疾病、未分化结缔组织病相关间质性肺疾病和特发性肺纤维化的特征比较:一项回顾性研究
Clin Dev Immunol. 2013;2013:121578. doi: 10.1155/2013/121578. Epub 2013 Sep 19.
9
Demographic and clinical predictors of progression and mortality in connective tissue disease-associated interstitial lung disease: a retrospective cohort study.结缔组织病相关间质性肺疾病进展和死亡的人口统计学和临床预测因素:一项回顾性队列研究。
BMC Pulm Med. 2019 Oct 31;19(1):192. doi: 10.1186/s12890-019-0943-2.
10
Connective tissue disease-related interstitial lung disease (CTD-ILD) and interstitial lung abnormality (ILA): Evolving concept of CT findings, pathology and management.结缔组织病相关间质性肺疾病(CTD-ILD)和间质性肺异常(ILA):CT表现、病理学及管理的概念演变
Eur J Radiol Open. 2022 Apr 7;9:100419. doi: 10.1016/j.ejro.2022.100419. eCollection 2022.

引用本文的文献

1
Dynamic macrophage phenotypes in autoimmune and inflammatory rheumatic diseases.自身免疫性和炎性风湿性疾病中的动态巨噬细胞表型
Nat Rev Rheumatol. 2025 Jul 28. doi: 10.1038/s41584-025-01279-w.
2
Pulmonary Involvement in Systemic Lupus Erythematosus: A Potentially Overlooked Condition.系统性红斑狼疮的肺部受累:一种可能被忽视的病症。
Biomedicines. 2025 Jun 16;13(6):1485. doi: 10.3390/biomedicines13061485.
3
Polydatin-curcumin formulation alleviates CTD-ILD-like lung injury in mice via GABBR/PI3K/AKT/TGF-β pathway.虎杖苷-姜黄素制剂通过GABBR/PI3K/AKT/TGF-β途径减轻小鼠CTD-ILD样肺损伤。

本文引用的文献

1
Macrophages in immunoregulation and therapeutics.巨噬细胞在免疫调节和治疗中的作用。
Signal Transduct Target Ther. 2023 May 22;8(1):207. doi: 10.1038/s41392-023-01452-1.
2
Management of interstitial lung disease in patients with autoimmune disease-related interstitial lung disease.自身免疫性疾病相关间质性肺病患者的间质性肺病管理
Multidiscip Respir Med. 2023 Apr 18;18(1):890. doi: 10.4081/mrm.2023.890. eCollection 2023 Jan 17.
3
Rheumatoid arthritis associated interstitial lung disease: Trends in epidemiology and mortality in Ontario from 2000 to 2018.
Front Pharmacol. 2025 Jun 5;16:1573525. doi: 10.3389/fphar.2025.1573525. eCollection 2025.
4
OM85 ameliorates bleomycin-induced pulmonary fibrosis in mice by inhibiting Notch expression and modulating the IFN-γ/IL-4 ratio.OM85通过抑制Notch表达和调节IFN-γ/IL-4比值改善博来霉素诱导的小鼠肺纤维化。
Sci Rep. 2025 Feb 13;15(1):5436. doi: 10.1038/s41598-025-89874-5.
5
Molecular Mechanisms, Diagnoses, and Treatments of Respiratory Diseases.呼吸系统疾病的分子机制、诊断与治疗
Biomedicines. 2024 Dec 24;13(1):4. doi: 10.3390/biomedicines13010004.
6
The immune mechanisms of acute exacerbations of idiopathic pulmonary fibrosis.特发性肺纤维化急性加重的免疫机制
Front Immunol. 2024 Dec 16;15:1450688. doi: 10.3389/fimmu.2024.1450688. eCollection 2024.
7
Clinical features, radiological findings and prognosis of microscopic polyangiitis with interstitial lung disease: a retrospective matched control study.显微镜下多血管炎合并间质性肺疾病的临床特征、影像学表现及预后:一项回顾性配对对照研究
BMC Pulm Med. 2024 Dec 9;24(1):605. doi: 10.1186/s12890-024-03423-w.
8
Prevalence of hybrid TLR4M2 monocytes/macrophages in peripheral blood and lung of systemic sclerosis patients with interstitial lung disease.伴有间质性肺病的系统性硬化症患者外周血和肺中混合性TLR4M2单核细胞/巨噬细胞的患病率。
Front Immunol. 2024 Nov 20;15:1488867. doi: 10.3389/fimmu.2024.1488867. eCollection 2024.
9
Exploring the Interplay between Cellular Senescence, Immunity, and Fibrosing Interstitial Lung Diseases: Challenges and Opportunities.探讨细胞衰老、免疫与纤维性间质性肺疾病之间的相互作用:挑战与机遇。
Int J Mol Sci. 2024 Jul 10;25(14):7554. doi: 10.3390/ijms25147554.
10
The Lung in Rheumatoid Arthritis-Friend or Enemy?类风湿关节炎中的肺-朋友还是敌人?
Int J Mol Sci. 2024 Jun 12;25(12):6460. doi: 10.3390/ijms25126460.
类风湿关节炎相关间质性肺疾病:2000年至2018年安大略省的流行病学和死亡率趋势
Respir Med. 2023 May 13:107282. doi: 10.1016/j.rmed.2023.107282.
4
Immune-mediated lung diseases: A narrative review.免疫介导的肺部疾病:一篇叙述性综述。
Front Med (Lausanne). 2023 Apr 6;10:1160755. doi: 10.3389/fmed.2023.1160755. eCollection 2023.
5
Inflammatory Biomarkers in the Diagnosis and Prognosis of Rheumatoid Arthritis-Associated Interstitial Lung Disease.类风湿关节炎相关间质性肺病的诊断和预后的炎症生物标志物。
Int J Mol Sci. 2023 Apr 5;24(7):6800. doi: 10.3390/ijms24076800.
6
Efficacy and Safety of Nintedanib in Patients with Connective Tissue Disease-Interstitial Lung Disease (CTD-ILD): A Real-World Single Center Experience.尼达尼布治疗结缔组织病相关间质性肺病(CTD-ILD)患者的疗效和安全性:一项单中心真实世界研究经验
Diagnostics (Basel). 2023 Mar 23;13(7):1221. doi: 10.3390/diagnostics13071221.
7
Recent advances in the treatment of systemic sclerosis associated interstitial lung disease.系统性硬化症相关间质性肺疾病治疗的最新进展
Front Med (Lausanne). 2023 Mar 24;10:1155771. doi: 10.3389/fmed.2023.1155771. eCollection 2023.
8
UGRP1-modulated MARCO alveolar macrophages contribute to age-related lung fibrosis.UGRP1调节的MARCO肺泡巨噬细胞促成与年龄相关的肺纤维化。
Immun Ageing. 2023 Mar 18;20(1):14. doi: 10.1186/s12979-023-00338-8.
9
Advances in cellular senescence in idiopathic pulmonary fibrosis (Review).特发性肺纤维化中细胞衰老的研究进展(综述)
Exp Ther Med. 2023 Feb 15;25(4):145. doi: 10.3892/etm.2023.11844. eCollection 2023 Apr.
10
N-Acetylcysteine attenuated pulmonary fibrosis induced by bleomycin immunomodulation responses.N-乙酰半胱氨酸减轻博来霉素诱导的肺纤维化免疫调节反应。
Res Pharm Sci. 2023 Jan 19;18(2):177-184. doi: 10.4103/1735-5362.367796. eCollection 2023 Apr.